HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab. [electronic resource]
Producer: 20130430Description: 560-5 p. digitalISSN:- 1468-2060
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Apolipoproteins A -- analysis
- Apolipoproteins B -- analysis
- Arthritis, Rheumatoid -- blood
- Atherosclerosis -- blood
- Cholesterol, HDL -- analysis
- Cholesterol, LDL -- analysis
- Female
- Humans
- Immunomodulation -- drug effects
- Male
- Middle Aged
- Proteomics
- Risk Factors
- Rituximab
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Treatment Outcome
- Triglycerides -- analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.